Protekt Therapeutics
Alzheimer’s disease drug | Protekt Therapeutics | Israel.
Launch date
Ness Ziona Center District (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$4.1m | Early VC | ||
| Total Funding | €3.7m | ||
Related Content
Recent News about Protekt Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.